16 Best Hormone therapy for prostate cancer Doctors in Istanbul

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Dr. Ilker Tinay is an urological oncologist at Anadolu Medical Center. He sits on the Executive Board of the Association of Urooncology. Dr. Tinay specializes in minimally invasive surgery and neo-bladder reconstruction. He works at Anadolu, a Top 10 global hospital according to MTQUA. The center is also affiliated with Johns Hopkins Medicine.

• Member of the American College of Surgeons and European Association of Urology.
• Secretary of the Bladder Tumours Research Group.
• Winner of the Urooncology Association Scientific Research Award.
• Performs complex procedures including robotic da Vinci prostatectomy and nephrectomy.

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Professor Mustafa Solak gained specialised expertise at the MD Anderson Cancer Center in the United States – consistently ranked as one of the world's top cancer hospitals.

• Completed an advanced fellowship at the Hacettepe University Cancer Institute
• Specialises in coordinating systemic treatments for advanced and complex malignancies
• Uses evidence-based protocols to manage hormone-sensitive tumours
• Experienced in administering targeted therapies and immunotherapy for solid tumours
• Supervises medical oncology care at Hisar Hospital Intercontinental in Istanbul

Professor Yesim Yildirim is an ESMO-certified medical oncologist at Anadolu Medical Center with over 80 scientific publications to her name. She completed advanced clinical training at Mount Vernon Cancer Center in the UK.

• Holds a Professor rank and a Hirsch index of 7 for research impact
• Focuses on precision medicine including targeted therapies and hormone therapy protocols
• Founded the Turkish Gastrointestinal Oncology Network to improve patient care standards
• Member of the American Society of Clinical Oncology and European School of Oncology
• Trained in immunology in Switzerland to better understand cancer cell behaviour

Associate Professor Heves Surmeli is the former Clinical Director of Medical Oncology at Kartal Dr Lütfi Kırdar Training and Research Hospital. She now leads complex cancer care at Hisar Hospital Intercontinental.

• Specialises in urological cancers including systemic hormone therapy protocols
• Served as Administrative Director for one of Istanbul's major oncology clinics
• Completed formal subspecialty fellowship training in Medical Oncology
• Active member of several international professional medical societies
• Published extensive research in peer-reviewed journals on oncological outcomes

Professor Eda Tanrıkulu Şimşek ranked third in Turkey's national medical specialty exam and leads clinical research into targeted cancer therapies at Anadolu Medical Center.

• Specialises in urological cancers using genetic profiling to match treatments to specific tumours
• Former Head of Medical Oncology at Haydarpaşa Numune Training and Research Hospital
• Lead researcher for international clinical trials focusing on emerging cancer therapies
• Member of the European Society for Medical Oncology and American Society of Clinical Oncology

Associate Professor Tahsin Ozatli is a senior clinical oncologist at Istinye University Liv Hospital, a premier medical facility in Istanbul.

• Promoted to Associate Professor status in 2016 for his academic and clinical expertise
• Trained at Selcuk University Faculty of Medicine – one of Turkey's established medical schools
• Practised oncology at Ankara Oncology Clinic, a specialized centre for cancer care
• Managed complex oncology cases at Erzurum Regional Training and Research Hospital

Professor Irfan Cicin is a senior medical oncologist and academic leader at İstinye University Liv Hospital Topkapı. He holds a professorship at Trakya University Faculty of Medicine and focuses on evidence-based cancer protocols.

• Specialised in medical oncology since completing his fellowship in 2004
• Serves as Professor of Medical Oncology at Trakya University
• Leads clinical research and treatment at İstinye University Liv Hospital Topkapı
• Completed specialist residency training at Istanbul University Cerrahpaşa Faculty of Medicine
• Expert in managing systemic therapies for complex urological oncology cases

Associate Professor Muhammed Mustafa Atci is a senior medical oncologist and Education Coordinator at Liv Hospital Topkapi, specialise in hormone-driven malignancies. He is a recognised member of the American Society of Clinical Oncology.

• Specialises in precise hormone therapy protocols for managing prostate cancer cases
• Researches advanced biomarkers for urological cancers to improve diagnostic accuracy
• Coordinates medical oncology education for specialist registrars and sub-branches
• Published 15+ peer-reviewed articles on tumour markers and treatment outcomes
• Member of the Turkish Society of Medical Oncology since 2018

Associate Professor Nail Paksoy is a European-certified oncologist who focuses on advanced medical treatments for prostate and uro-oncological cancers at Medipol Hospital.

• ESMO Board Certified in Medical Oncology, recognised by the European Society for Medical Oncology
• Active subinvestigator in international clinical trials for targeted cancer therapies
• Published research on PSMA-based tumour burden and outcomes in prostate cancer
• Specialised fellowship training at the Istanbul University Oncology Institute
• Expertise in administering complex hormone and immunotherapy protocols

Professor Abdullah Sakin leads the medical oncology team at Medipol Mega University Hospital, where he specialises in precision oncology for genitourinary cancers.

• Provides evidence-based hormone therapy for advanced prostate cancer cases
• Uses precision oncology to tailor treatments to specific genetic markers
• Active in international clinical research with 200+ scientific publications
• Member of the Turkish Medical Oncology Association
• Focuses on balancing treatment efficacy with patient quality of life

Professor Gul Alco lead radiation oncology efforts at Medipol Mega University Hospital, focusing on adaptive radiotherapy for precise cancer targeting.

• Specialises in adaptive radiotherapy to adjust treatment based on tumour changes
• Utilises radiosurgery techniques for high-dose precision in prostate cases
• Delivers evidence-based care within a multidisciplinary oncology team
• Expertise spans central nervous system and soft tissue tumours
• Focuses on patient-centred protocols to reduce treatment side effects

Associate Professor Abdullah Sakin is a former Head of Medical Oncology who specialised in complex cancer care at major Turkish university hospitals.

• Served as the Education Officer at the Prof Dr Cemil Tascioglu City Hospital, training the next generation of oncologists
• Led the Department of Medical Oncology at Yuzuncu Yil University Faculty of Medicine
• Board-certified medical oncologist with extensive training from Okmeydani Training and Research Hospital
• Focuses on evidence-based medication protocols for hormone-dependent malignancies